Connect Biopharma Holdings (CNTB) Net Equity Issued and Repurchased (2025 - 2026)

Connect Biopharma Holdings (CNTB) posted quarterly Net Equity Issued and Repurchased of $137000.0 for Q1 2026, up 6750.0% year-on-year from $2000.0 in Q1 2025, and up 6750.0% on a QoQ basis from $2000.0 in Q1 2025.

Connect Biopharma Holdings (CNTB) Net Equity Issued and Repurchased (2025 - 2026) Analysis & Trends

Connect Biopharma Holdings (CNTB) has reported Net Equity Issued and Repurchased for 2 consecutive years, with $137000.0 the latest figure, recorded in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 141.90 Mn
10 Connect Biopharma Holdings 120.44 Mn 120.44 Mn - 137,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 137,000.00
Mar 31, 2026 137,000.00
Mar 31, 2025 2,000.00
Mar 31, 2025 2,000.00